Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Expert Opinion on Investigational Drugs|July 4, 2009
EGFR-directed therapies to treat non-small-cell lung cancerCheryl Ho, Janessa Laskin
Expert Review of Anticancer Therapy|October 31, 2006
A new era for bronchioloalveolar carcinoma: current state of the art and recent advances in biologically targeted therapyBalvindar S Johal, Janessa Laskin
Lung Cancer (Amsterdam, Netherlands)|January 21, 2015
Maintenance chemotherapy in advanced NSCLC: a population-based assessment of eligibilityKing Mong Tong, Janessa Laskin, Cheryl Ho
Human Resources for Health|June 29, 2017
Knowledge, attitudes, and values among physicians working with clinical genomics: a survey of medical oncologistsPeter Chow-White, Dung Ha, Janessa Laskin
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Adherence to surveillance guidelines in resected NSCLC: Physician compliance and impact on outcomesCheryl Ho, Jennifer Siegfried, Karen Remo, et al.
World Journal of Oncology|November 18, 2017
Locally Advanced Cutaneous Squamous Cell Carcinoma: Two Case Reports of Dramatic Responses to Sequential Cisplatin, Docetaxel and RadiotherapyKristopher E Dennis, Charmaine Kim-Sing, Janessa Laskin
Thyroid Research|September 22, 2017
A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapyGeorgia Geller, Janessa Laskin, Winson Y Cheung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2015
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical TrialsKrista L Noonan, Cheryl Ho, Janessa Laskin, et al.
Pageof 12